1. Zakharov S.G., Golenkov A.K., Mitina T.A., Luts-kaya T.D., Belousov K.A., Fadeev R.S., Solovyova M.E., Senatov A.S., Akatov V.S. 2014. Increasing drug resistance of acute myeloblastic leukemia cells in multicellular aggregates in vitro.
Almanakh Klinicheskoy Meditsyni (Rus.). 31, 11–16.
2. Fadeev R.S., Solov’eva M.E., Sadovsky D.A., Zakha-rov S.G., Fadeeva I.S., Senotov A.S., Dolgikh N.V., Golenkov A.K., Akatov V.S. 2015. Cell aggregation increases drug resistance of acute myeloid leukemia cells. Biologicheskie membrany (Rus.). 32 (2), 125–134.
3. Ishiguro T., Ohata H., Sato A., Yamawaki K., Enomoto T., Okamoto K. 2017. Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications. Cancer Sci.
108 (3), 283–289.
4. Rodrigues T., Kundu B., Silva-Correia J., Kundu S.C., Oliveira J.M., Reis R.L., Correlo V.M. 2018. Emerging tumor spheroids technologies for 3D in vitro cancer modeling. Pharmacol. Ther.
184, 201–211.
5. Riffle S., Pandey R.N., Albert M., Hegde R.S. 2017. Linking hypoxia, DNA damage and proliferation in multicellular tumor spheroids. BMC Cancer.
17 (1), E338.